95843 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds without P—C bonds; Esters of oxyacids of phosphorus; Esters of phosphoric acids; Phosphatides, e.g. lecithin Adducts, complexes, salts of phosphatides
CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS
#2IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
#3STABLE NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#4METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS
#5IMMUNOMODULATORY LIPIDS AND USES THEREOF
#6LIPID ANALOGS AND LIPOSOMES COMPRISING SAME
#7POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
#8COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF INFLAMMATORY, DEGENERATIVE, AND NEURODEGENERATIVE DISEASES
#9RED-SHIFTED PHOTOLIPIDS AND NANOPARTICLES FORMED FROM SAME
#10Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#11METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS
#12FUNCTIONAL IONIZABLE PHOSPHOLIPIDS
#13PHOSPHOLIPID
#14Methods for making ultrasound contrast agents
#15Lipid analogs and liposomes comprising same
#16IONIC LIQUID, SOLVENT, PREPARATION, AND TRANSDERMALLY ABSORBABLE AGENT
#17SELF-AGGREGATING HYDROUS PHOSPHOLIPID AND PREPARATION METHOD THEREOF
#18Ionizable compounds and compositions and uses thereof
#19Methods for making ultrasound contrast agents
#20Methods for making ultrasound contrast agents
#21Methods for making ultrasound contrast agents
#22Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#23METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS
#24Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#25Methods for making ultrasound contrast agents
#26Plasmalogen derivatives
#27Lipid analogs and liposomes comprising same
#28Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#29Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#30Low-fat water-in-oil emulsion
#31Method for making a solid-supported phospholipid bilayer
#32In situ lipid synthesis for protein reconstitution
#33NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS
#34Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#35Endosomolytic agents for gene therapy
#36Compositions for transfecting resistant cell types
#37Methods for making ultrasound contrast agents
#38Process for the purification of L-α-glycerophosphorylcholine
#39Methods for making ultrasound contrast agents
#40Stable nanolipoprotein particles and related compositions methods and systems
#41Ionizable compounds and compositions and uses thereof
#42Phospholipid preparations for the improvement of brain plasticity
#43Lipid analogs and liposomes comprising same
#44Oxidized lipids and treatment or prevention of fibrosis
#45Lipophenol compounds and uses thereof
#46Phospholipid nanogel for exoglycosidase enzyme stabilization
#47Texaphyrin-phospholipid conjugates and methods of preparing same
#48Liquid developer and method of producing same
#49Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#50Natural lipids containing non-oxidizable fatty acids
#51Siloxane-containing phospholipids, compositions and uses thereof
#52Oxidized lipids and treatment or prevention of fibrosis
#53GENETICALLY MODIFIED COCCIDIAN PARASITES USEFUL AS VACCINES
#54Functional lipid constructs
#55Biocompatible, biomimetic ampholyte materials
#56PROCESS FOR THE PURIFICATION OF L-ALPHA-GLYCEROPHOSPHORYLCHOLINE
#57Lipophenol compounds and uses thereof
#58Method for acquiring one or a plurality of recyclable materials from seeds
#59Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#60Ionizable compounds and compositions and uses thereof
#61Stereospecific lipids for locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems
#62Targeted delivery of anti-fungal agents
#63Phosphatidylalkanols and compositions thereof
#64Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring
#65Boron cluster-modified PEG lipid derivative, and molecular assembly using same
#66High-purity phospholipids
#67Method for producing phospholipid-containing composition, and phospholipid-containing composition
#68Targeting delivery of anti-fungal agents
#69Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
#70Functional lipid constructs
#71Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
#72Method for the synthesis of porphyrin-phospholipid conjugates
#73High-purity phospholipids
#74Process for the preparation of oxidized phospholipids
#75Polymerisable material
#76Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
#77High-purity phospholipids
#78Biocompatible, biomimetic ampholyte materials
#79Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#80COMPOSITIONS FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
#811-hydroxy-2-O-acyl-sn-glycero-3-phosphocholine compounds, preparation process, antifouling composition, process for its preparation, method to prevent fouling, method to turn a surface into an antifouling surface, and, covered surface
#82PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS
#83Mixtures of and methods of use for polyunsaturated fatty acid-containing phospholipids and alkyl ether phospholipids species
#84PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING
#85Functional lipid constructs
#86ORGANOGEL COMPOSITIONS AND PROCESSES FOR PRODUCING
#87ANTI-PAF ANTIBODIES
#88Oxidized lipid compounds and uses thereof
#89Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#90Process for the production of N-acyl-phosphatidyl-ethanolamine
#91Redox-gated Liposomes
#92Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#93METHOD AND PROCESS FOR PREPARING CARDIOLIPIN
#94Process for the preparation of oxidized phospholipids
#95COMPOUND, DIAGNOSTIC AGENT, NUCLEAR MAGNETIC RESONANCE ANALYSIS METHOD, NUCLEAR MAGNETIC RESONANCE IMAGING METHOD, MASS SPECTROMETRY METHOD AND MASS SPECTROMETRY IMAGING METHOD
#96NOVEL LIPID COMPOUNDS
#97Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
#98Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
#99Preparation of Heavy Metal-Containing Nano-Liposomes and their Uses in Medical Therapy
#100BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF
#101Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#102Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR)
#103Anti-Inflammatory and Anti-Allergy Extracts from Nettle
#104Methods for the diagnosis of dementia and other neurological disorders
#105Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#106MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES
#107Oxidized phospholipids
#108Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
#109Synthesis of Cardiolipin Analogues and Uses Thereof
#110Lipid analogs for combating tumors
#111Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#112Method for removing enzyme and method of base exchange or hydrolysis of phospholipid using the same
#113Two-photon dyes for real-time imaging of lipid rafts
#114Non-natural sphingolipid analogs and uses thereof
#115MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES
#116Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
#117Phospholipid derivatives of non-steroidal anti-inflammatory drugs
#118Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure
#119Stabilized formulations of phosphatidylserine
#120Process for the preparation of oxidized phospholipids
#121Lipid analogs for inhibiting HIV-1 activity
#122Lipid analogs for inhibiting the activity of hepatitis B antigen
#123Lipid analogs for combating tumors
#124Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#125Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
#126Liposome stabilizing agent
#127Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#128Lipid analogs for treating viral infections